MORE►
inherited retinal diseases
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
Dallas’ Nanoscope Therapeutics Hires Chief Technology, Manufacturing Officer
by Lance Murray | Dec 6, 2024
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
by Lance Murray |
May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
MORE►
